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Abstract
Introduction: Asthma is a serious health and social problem, also in Poland. The epidemiological data indicate that the problem 
of asthma concerns approximately 4 million people in Poland, whereas almost approximately 70% of them have no diagnosis 
and are not aware of their illness, and on the other hand in 39% of persons who declared the diagnosis of asthma in a survey the 
diagnosis was negatively verified (overdiagnosis of asthma). So far, no detailed comparative studies for asthma incidence rate in 
urban and rural areas were conducted in Poland.
The aim of the study was to analyze patients with asthma in Poland in the years 2008−2012, with regard to province and type 
of commune (rural/urban).
Material and methods: The study used data from National Health Fund (NFZ) — reported by health care providers regarding the 
patients diagnosed with asthma. Using structured query language (SQL) a set of patients was selected and created, for whom 
at the same time ICD-10 code: J45.X-bronchial asthma was reported. In order to estimate the number of patients with asthma 
we used the PESEL social security number as a unique identifier of the patient. Code of the patient’s commune of residence in 
conjunction with the Central Statistical Office data formed the basis for the division of municipalities into urban and rural areas. 
The analysis of asthma incidence trends in Poland was performed on the basis of health services provided to patients. The analysis 
was performed by using the Statistica 10 software using a negative binomial regression model.
Results: In 2009 a significant increase in the number of patients with asthma was observed compared with the previous year, 
whereas after 2009 the number of patients diagnosed with asthma remained relatively constant. A significant increase of pre-
dominance of women among asthma patients in recent years can be noticed: from 107% in 2008 to almost 115% in 2012 (F:M 
ratio). Regardless of the analyzed year and the diagnosis the incidence rate remained constant: approximately 55−57% for urban 
areas and about 43−45% in rural areas.
Conclusions: The average prevalence rate for rural areas is significantly lower than for urban areas. The use of adjusted incidence 
rate leads to the conclusion that the number of sufferers in urban areas is higher (about 10%) of the number of sufferers in the rural 
areas. The results of the analysis are consistent with information from previous studies in Poland and in the world.
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Streszczenie
Wstęp: Astma  jest ważnym problemem zdrowotnym i socjalnym na świecie oraz w  Polsce.  Dostępne dane epidemiologiczne 
wskazują, że problem astmy dotyczy prawie 4 mln osób w Polsce, podczas gdy około 70% z nich nie ma postawionej diagnozy 
i nie są świadomi swojej choroby. Jednocześnie około 39% chorych z postawioną diagnozą astmy jest następnie negatywnie 
weryfikowana (nadrozpoznawalność astmy). Do tej pory brakuje szczegółowych badań porównawczych astmy w regionach 
wiejskich i miejskich. 
Celem badania była analiza danych chorych na astmę w Polsce w latach w latach 2008−2012 w odniesieniu do województw 
oraz typu gminy (wiejskie/miejskie).
Materiał i metody: W badaniu zastosowano analizę danych NFZ — sprawozdawanych przez świadczeniodawców — pacjentów 
ze zdiagnozowaną astmę. Przy zastosowaniu SQl (structured query language) wyodrębniono i utworzono zbiory pacjentów dla któ-
rych sprawozdano kod ICD-10: J45.X- dychawica oskrzelowa. W celu oszacowania liczby pacjentów wykorzystano numer PESEL, 
jako unikalny identyfikator pacjenta. Kod gminy miejsca zamieszkania w połączeniu z danymi Głównego Urzędu Statystycznego 
był podstawą podziału gmin na regiony miejskie i wiejskie. Analizę trendu zachorowalności na astmę w Polsce wyliczono na pod-
stawie udzielonych pacjentom świadczeń zdrowotnych. Analizę przeprowadzono za pomocą narzędzia Statistica 10, korzystając 
z modelu ujemnej regresji binominalnej.
Wyniki: W 2009 roku obserwowano istotne zwiększenie liczby chorych na astmę w porównaniu z rokiem poprzednim, natomiast 
po 2009 roku liczba pacjentów z rozpoznaniem astmy pozostawała na względnie st ałym poziomie. Zwraca uwagę istotny wzrost 
w ostatnich latach przewagi kobiet wśród chorych na astmę: ze 107% w 2008 roku do prawie 115% w 2012 roku (stosunek K:M). 
Niezależnie od badanego roku i  rozpoznania utrzymuje się stały współczynnik zachorowalności: około 55−57% dla regionów 
miejskich i około 43−45% dla regionów wiejskich. 
Wnioski: Średni wskaźnik chorobowości dla regionów wiejskich jest istotnie niższy niż dla regionów miejskich. Zastosowanie 
skorygowanego współczynnika zachorowalności pozwala na stwierdzenie, że liczba chorujących w regionach miejskich jest 
większa (o około 10%) od liczby chorujących w regionach wiejskich. Wyniki analizy są zbieżne z informacjami z wcześniejszych 
badań w Polsce i na świecie.
Słowa kluczowe: astma, chorobowość, epidemiologia astmy
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Introduction
Asthma is a chronic inflammatory disease of 
the respiratory tract. This illness is a significant 
social and economical problem due to its symp-
toms, which significantly impact the quality of 
life, and frequently also the life expectancy of 
patients, but also due to its prevalence: in ac-
cordance with epidemiological data up to 10% 
of Polish population suffers from asthma (*ECAP 
study). The definition of asthma, which was first 
published in the GINA document in 1993 is con-
stantly modified as the knowledge on the complex 
pathogenesis and phenotypes of the illness is 
being complemented. The definition currently 
in force describes asthma as: “heterogeneous 
disease, usually characterized by chronic airway 
inflammation”.
It is defined by the history of respiratory 
symptoms such as wheeze, shortness of breath, 
chest tightness, and cough that vary over time 
and in intensity, together with variable expiratory 
airflow limitation” (*GINA2014).
This definition shows clearly that the diag-
nosis of asthma is a clinical diagnosis, in practice 
not based on objective criteria. This results in the 
diagnostics of this illness being difficult and high-
ly dependent on the experience and knowledge 
of the medical practitioner [1, 2]. Additionally 
the complicated pathogenesis of the disease, the 
variation of its symptoms, the geographic diver-
sification of its occurrence, the impact of age, 
method of disease treatment (disease control) 
and co-existing diseases result in a  frequently 
inaccurate epidemiological assessment, resulting 
from either overdiagnosing or, as frequently, un-
derdiagnosing the incidence of disease.  
Health services in Poland are financed by the 
National Health Fund (NFZ), pursuant to the Act 
[3] and the Regulation of the Minister of Health 
resulting thereof [4]. Treatment of respiratory 
tract diseases is performed within a framework of 
a health services provision contract. The rules of 
organisation, financing and settling of the services 
are in accordance with the NFZ President’s Regu-
lations [5]. Due to the organisation of health care 
in Poland, asthma is most frequently diagnosed by 
primary health care physicians and by pulmonary 
pulmonary medicine or allergology specialists. 
Most frequently these diagnoses are treated as 
initial and requiring confirmation, established as 
observation for asthma. 
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Epidemiology of asthma
It is estimated that over 300 million people 
suffer from asthma worldwide — depending on 
the study the data indicate the presence of the 
disease among 1−18% of the general population 
[6−11]. It is estimated that solely in Europe ap-
prox. 30 million people are treated for asthma 
[8]. Most frequently the course of asthma is mild 
or moderate. This means that full control is ob-
tained with the use of small or moderate doses 
of drugs which modify the course of the disease. 
However in approximately 5% of patients heavy 
asthma is present, which requires the use of high 
doses of drugs. This is frequently connected to 
occurrence of adverse effects (frequently serious), 
while not always leading to the management of 
symptoms. This results in significant increase of 
treatment costs, resulting from the increase of 
the number of unplanned visits, emergency (ER) 
visits, hospitalisations, and also from the feeling 
of being sick, absenteeism at work and many other 
indirect costs. It is estimated that almost 95% of 
all resources assigned to asthma therapy is used 
for the treatment of this group (5% of patients).
Reaching further into pharmacoeconomic 
data it is estimated that the treatment of asthma 
accounts for 1% to 2% of expenses for the treat-
ment of chronic diseases and 15 million of DALYs 
(disability-adjusted life years). Although in de-
veloped countries the incidence rate has reached 
a plateau, in countries where these indicators 
where on a low level so far a significant increase of 
incidence rate can be observed currently [12, 13]. 
Asthma is a serious health and social prob-
lem, also in Poland. The epidemiological data 
indicate that the problem of asthma concerns ap-
proximately 4 million people in Poland, whereas 
almost 70% of them have no diagnosis and are 
not aware of their illness, and on the other hand 
in 39% of persons who declared the diagnosis of 
asthma in a survey the diagnosis was negatively 
verified (overdiagnosis of asthma) [14]. At the 
same time in the group of allergic diseases asthma 
is first in the ranking of absence caused by dis-
ease, of hospitalisation, disability and death [9]. 
Approximately 1500 patients die annually in Po-
land due to asthma complications. The character 
of the disease, that is, the chronic or recurrent 
symptoms of airway limitation mean that asth-
ma has a significant impact also on  factors such 
as quality of life, efficiency in work, absences 
caused by disease, frequency of hospitalisation or 
social activity. This results in high economic and 
social costs, the assessment of which is difficult. 
Although the assessment of costs performed as 
a part of epidemiological studies is accurate, it 
is also expensive and possible to be conducted 
only as a part of a certain section of population. 
The high costs of these studies prevent them 
from being repeated in intervals which would 
enable the assessment of trends over time. For 
this reason attempts at using secondary sources 
of information, such as disease registries, data on 
temporary inability to work, hospital statistics 
or outpatient treatment statistics for the studies 
of direct and indirect costs of asthma have been 
made. Although these data have some error 
resulting from the inaccuracy of diagnoses, in-
completeness of data or difficulty in establishing 
the population exposed to risk, they do enable 
a much wider assessment: it is possible not only 
to assess the full population which inhabits 
the given area, but also to observe changes and 
trends over time, on which the aforementioned 
error should have no significant impact. Thus 
one may assume that the use of data sources con-
cerning the use of reimbursed medical products, 
the use of health care services, such as medical 
consultation, ER visits or hospitalisations and 
information concerning social costs of asthma 
(medical leave — ZUS social security databases) 
may enable more complete assessment of treated 
population, and as a consequence the monitoring 
of asthma incidence rate. Complex multivariate 
analysis should also enable establishing the dy-
namics of asthma incidence rate and establishing 
the factors which may influence the occurrence 
of the disease, its clinical picture (phenotype) 
and its course. 
So far only few studies were carried out on 
the epidemiology of asthma in Poland.  One of 
them — PMSEAD (acronym The Polish Multi-
centre Study of Epidemiology of Allergic Dis-
eases) (22), was designed to obtain estimates 
representative of the entire Polish population 
to assess asthma prevalence and risk factors. 
It was  conducted in 11 regions of Poland, each 
of which was  divided to three parts and one part 
was a rural area. In another big epidemiological 
study named ECAP a single rural area (2055 sur-
veyed persons) was compared with eight urban 
areas (cities with population exceeding 100,000 
— 15,562 surveyed persons). Significant disparity 
between the study population and the population 
residing in Poland (rural population is approxi-
mately 40% of the population of Poland) may be 
a source of significant error in both studies, just 
like a  relatively small cohort compared to the 
country population.
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Currently the data concerning the health 
care services performed for patients which are 
delivered by the service providers to the National 
Health Fund province Departments and collected 
by the National Health Fund enable the collective 
analysis of the population of asthma patients in 
Poland.
The work has described the results of asthma 
patients’ data analysis in the years 2008–2012. 
The following were estimated:  
1. Number of asthma patients, depending on 
whether the area is urban or rural. 
2. Prevalence indicator (per 10,000 inhabitants), 
taking into account the type of commune, 
divided by province. 
3. Prevalence indicator (per 10,000 inhabitants), 
taking into account the type of commune.
4. Prevalence indicator (per 10,000 inhabitants), 
divided by province.
Material and methods
The asthma prevalence database was con-
structed based on the data reported to NFZ by 
the service providers. The data of patients for 
whom ICD-10: J45.X — asthma code was reported 
was selected from the IT systems which store the 
information on patients reported in settlement 
reports. The study used the following data from 
the data reported in statistical reports:
a)  unique patient identifier (PESEL number),
b)  diagnosis (ICD-10 code) and 
c)  residence identifier (commune code). 
PESEL number and the diagnosis code ena-
ble rather accurate estimation of the number 
of asthma patients. The place of residence in 
turn enables identification of the type of com-
mune. The lack of data applies to cases where 
services were provided to homeless people, 
for example. In the studied period the share 
of unidentified data was small and statistical-
ly insignificant and amounted to an average 
of 0.28% (respectively: 2008 — 0.25%; 2009 
— 0.30%; 2010 — 0.27%; 2011 — 0.29% and 
2012 — 0.31%). The data was collected from 
the databases using SQL tools, using a filter in 
accordance with the accepted scope of ICD-10 
diagnoses. The analysis was conducted using 
Excel and Statistica 10 tools, using a negative 
binomial regression model. The demographic 
data was collected from the Central Statistical 
Office website [15]. 
The analysis of the asthma incidence rate 
trends in Poland calculated based on the health 
services provided to the patients was compared 
to the results of obtained studies, in which the 
following protocols were used: International Stu-
dy of Asthma and Allergies in Childhood (ISAAC) 
and European Community Respiratory Health 
Survey (ECRHS).
Results
The population of asthma patients in Poland 
during the years 2008−2012 depending on sex 
was established in Table 1.
In the year 2009 a significant increase of the 
number of patients with asthma was observed 
compared to the previous years, whereas after 
2009 the number of patients with a diagnosis of 
asthma remained at a  relatively constant level. 
A significant increase of the predominance of 
women among asthma patients during the last 
years can be noticed: from 107% in 2008 to almost 
115% in 2012 (the F:M ratio).
The population of asthma patients in Poland 
during the years 2008-2012 depending on the 
place of residence, with an additional division 
into asthma diagnosis subgroups: J45.0 — pre-
dominantly allergic asthma, J45.1 — nonaller-
gic asthma, J45.8 — mixed asthma and J45.9 
— unspecified asthma was established in Table 
2. Since approximately 40% of the population 
inhabits rural areas and 60% — urban areas, 
Table 1. Number of asthma patients divided according to sex, in 2008−2012
Tabela 1. Liczba pacjentów z astmą w podziale na płeć w latach 2008−2012
2008 2009 2010 2011 2012 
Women 467,126 592,534 604,274 618,334 623,079
Men 437,141 554,913 561,871 562,297 543,239
No data 1857 2184 1923 2131 2353
Final total 906,124 1 149,631 1,168,068 1,182,762 1,168,671
W/M ratio 106.86% 106.78% 107.55% 109.97% 114.70%
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a corrected percentage value of asthma incidence 
rate for the inhabitants of rural and urban areas 
was calculated using the following formula:
If UI = inhabitants of urban areas, and RI = 
inhabitants of rural areas, then 
Corrected prevalence  
indicator in rural areas =
1.25 RI
× 100%
1.25 RI + 0.83 UI
Corrected prevalence  
indicator in urban areas =
0.83 UI
× 100%
1.25 RI + 0.83 UI
Similarly to the previous chart a significant 
increase of the number of asthma patients com-
pared to the previous year could be observed in 
2009. A higher precision in the provision of asthma 
aetiology information can be noticed since 2011: 
the number of J.45 diagnoses is decreased compa-
red to J.45.x (unspecified, mixed, nonallergic or 
Table 2.  Number of patients divided into asthma diagnosis subgroups in Poland in urban and rural areas in the years 
2008−2012
Tabela 2.  Liczba pacjentów w podziale na rozpoznania w obszarach miejskich i wiejskich w Polsce w latach 2008−2012
Diagnosis 2008 2009 2010 2011 2012
J45 831,676 1,073,920 1,088,891 1,077,175 987,106
 urban (60% of population) 544,618 692,631 701,030 693,429 635,114
Corrected prevalence (%) 56% 55% 55% 55% 55%
 rural (40% of population) 285,050 378,839 385,663 381,444 349,710
Corrected prevalence (%) 44% 45% 45% 45% 45%
J45.0 75,594 83,562 81,336 133,390 179,108
 urban 49,880 54,746 53,641 87,632 117,212
Corrected prevalence (%) 56% 56% 56% 56% 56%
 rural 25,524 28,640 27,543 45,543 61,601
Corrected prevalence (%) 44% 44% 44% 44% 44%
J45.1 11,432 13,640 13,900 25,251 38,675
 urban 8,203 9,787 9,988 17,831 27,406
Corrected prevalence (%) 63% 63% 63% 61% 62%
 rural 3,210 3,828 3,889 7,398 11,202
Corrected prevalence (%) 37% 37% 37% 39% 38%
J45.8 11,720 13,705 13,743 23,212 35,710
 urban 8,023 9,097 9,069 15,013 23,277
Corrected prevalence (%) 59% 57% 56% 55% 55%
 rural 3,663 4,585 4,635 8,172 12,394
Corrected prevalence (%) 41% 43% 44% 45% 45%
J45.9 29,497 40,762 43,361 73,553 119,355
 urban 18,804 26,261 27,802 47,069 76,981
Corrected prevalence (%) 54% 55% 54% 54% 55%
 rural 10,566 14,330 15,402 26,274 42,100
Corrected prevalence (%) 46% 45% 46% 46% 45%
TOTAL: 959,919 1,225,589 1,241,231 1,332,581 1,359,954
predominantly allergic asthma). The observation 
that regardless of the studied year and diagnosis 
the incidence rate remains constant: approxima-
tely 55−57% for urban areas and approximately 
43−45% for rural areas is rather interesting. The 
nonallergic asthma, which is much more frequen-
tly diagnosed in cities than in rural areas: 63:37 is 
a single exception. The use of a corrected incidence 
rate enables stating that the number of patients in 
urban areas is higher (by approximately 10%) from 
the number of patients in rural areas (Table 3).
 The province with the highest prevalence 
indicator is the Świętokrzyskie province (13) 
(years 2008−2011) and Wielkopolskie province 
(15) in 2012.  The lowest indicator was noted 
in the Podlaskie province (10) in all the years 
included in the study. The marked trend line 
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Table 3.  Asthma morbidity indicator (with a J45.X diagnosis) per 10,000 inhabitants divided by province and region in the 
years 2008−2012
Tabela 3.  Wskaźnik chorobowości astmy (z rozpoznaniem J45.X) na 10 000 mieszkańców  w podziale na województwa 
i regiony miejskie/wiejskie w latach 2008−2012 
Province/region 2008 2009 2010 2011 2012
Dolnośląskie 190.97 273.50 265.88 253.81 251.17
 urban 203.67 289.39 280.51 271.01 269.00
 rural 157.95 233.70 229.43 212.54 208.35
Kujawsko-Pomorskie 266.26 300.79 308.16 307.93 303.59
 urban 272.45 312.57 321.37 323.80 318.53
 rural 178.46 280.79 285.96 281.57 278.54
Lubelskie 271.51 318.28 317.48 318.40 300.66
 urban 316.45 363.03 359.43 359.29 340.33
 rural 230.73 278.42 279.97 282.00 265.21
Lubuskie 173.68 265.59 259.81 251.80 252.85
 urban 187.53 280.58 273.99 267.51 267.58
 rural 148.13 237.73 233.64 223.49 225.47
Łódzkie 174.28 273.85 282.10 294.47 304.53
 urban 196.52 301.53 308.43 321.78 336.21
 rural 132.66 222.46 233.74 245.26 247.81
Małopolskie 276.64 337.45 338.25 327.04 321.60
 urban 304.91 363.53 361.06 350.81 350.31
 rural 247.61 310.47 314.58 302.94 292.87
Mazowieckie 223.81 263.75 274.35 279.37 269.51
 urban 231.01 270.82 284.31 290.76 282.30
 rural 208.38 248.39 254.12 256.23 244.37
Opolskie 172.50 252.15 261.29 262.70 264.99
 urban 206.28 294.19 305.62 308.09 302.60
 rural 132.85 202.82 209.19 208.66 219.04
Podkarpackie 216.26 301.20 313.21 315.07 340.97
 urban 265.63 338.98 350.16 353.65 384.53
 rural 181.31 273.83 286.43 286.89 309.47
Podlaskie 164.78 213.64 224.10 229.61 248.62
 urban 182.45 234.06 245.61 248.43 271.21
 rural 138.04 181.70 189.97 199.83 212.64
Pomorskie 270.43 331.28 337.13 344.66 326.77
 urban 290.18 349.95 350.62 360.47 341.86
 rural 229.66 293.05 308.68 311.92 295.07
Śląskie 274.15 324.82 335.19 342.81 319.70
 urban 275.79 325.65 338.46 346.67 324.22
 rural 264.91 318.06 320.56 326.25 300.32
Świętokrzyskie 287.56 360.24 373.36 371.93 329.48
 urban 350.52 415.13 421.46 416.97 373.27
 rural 234.81 313.73 332.72 333.87 292.21
Warmińsko-mazurskie 251.31 290.87 259.13 256.68 269.43
 urban 269.54 311.28 275.65 275.33 289.09
 rural 222.71 258.88 233.28 228.35 239.38
Wielkopolskie 244.12 335.70 347.39 349.35 363.14
 urban 263.96 360.98 375.68 383.76 398.33
 rural 217.50 302.14 309.93 304.83 317.12
Zachodniopomorskie 251.36 316.31 312.86 309.71 317.72
 urban 273.85 344.41 338.65 335.23 343.24
 rural 200.40 251.70 253.80 251.07 258.25
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Figure 1. Asthma prevalence indicator per 10,000 inhabitants, on the left side — urban areas, on the right side — rural areas (1−16 — numbers 
of the fund branches), dotted line shows the trend (which is similar in both regions)
Rycina 1. Wskaźnik częstości występowania astmy na 10 000 mieszkańców województwa, z lewej strony obszary miejskie, z prawej strony obszary 
wiejskie (1−16  — liczba oddziału funduszu), przerywana linia pokazuje trend (podobny w obu regionach)    
Figure 2. Value of the prevalence indicator per 10,000 inhabitants divided by regions, compared to the average for Poland in the years 2008−2012
Rycina 2. Wartość wskaźnika zachorowalności na 10 000 mieszkańców województwa w podziale na regiony w odniesieniu do średniej dla Polski 
w latach 2008−2012  
indicates a  similar behaviour of the incidence 
rate regardless of the region (similar gradient of 
the trend curve).
The diagram presented on Figures 2 demon-
strate that the average value of prevalence indi-
cator for rural areas is significantly lower than 
for urban areas, which corresponds to the results 
obtained by other studies. This situation may 
be caused by the way of living of the urban in-
habitants, that is more sterile living conditions, 
exaggerated hygiene or higher environmental 
pollution in urban areas. 
The highest average value of prevalence in ur-
ban areas occurs in the Świętokrzyskie province, 
which was demonstrated in Table 2. The lowest 
values are the Podlaskie and Lubuskie provinces. 
For the rural areas the largest indicator was not-
ed in the following provinces: Świętokrzyskie, 
Wielkopolskie, Śląskie and Małopolskie, and the 
lowest one in Podlaskie province (Fig. 3). 
Discussion and conclusions
The second half of the 20th century is the 
period of significant increase of incidence of 
allergic diseases, which are currently one of the 
largest public health problems [16]. Asthma is an 
important allergic disease, due to, among others, 
generation of relatively high social costs. This is 
why epidemiological studies concerning asthma 
incidence are so important. Conducting them is 
difficult, however, due to the aforementioned 
problems with asthma diagnosis, varying course 
or different phenotypes of the disease. Epidemi-
ological studies of this disease may use different 
sources of data listed below:  
1. Self-reported data questionnaires, where the 
patient enters information on key symptoms 
of asthma. These questionnaires are usual-
ly prepared for widely conducted clinical 
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Figure 3. Average value of the prevalence indicator per 10,000 inhabitants of the province for the years 2008−2012 divided by provinces
Rycina 3. Średnia wartość wskaźnika zachorowalności na 10 000 mieszkańców województwa  dla lat 2008−2012
studies of asthma. Their advantage is a  low 
price, which enables studying a relatively high 
population, and their disadvantage is the pro-
blems patient has with recalling symptoms, as 
well as individual perception of ailments. 
2. Data on hospitalisation for asthma.
3. Data resulting from the anti-asthma drug 
prescriptions.
Depending on the used source of informa-
tion data on asthma prevalence differ significant-
ly. In a prospective study conducted on a group 
of children in Denmark, which has compared the 
3 assessment methods listed above, prevalence 
was estimated at 32% based on prescription data, 
self-reported data questionnaires enabled the di-
agnosis of the disease in 12% of the population, 
whereas hospitalisation registries diagnosed 
asthma in only 6.6%.  Moreover, the combination 
of the three methods enabled the averaging of 
the prevalence on a  level of only 3.6%, which 
means that the groups established using various 
methods mostly do not overlap: it was estab-
lished that these methods are significantly dif-
ferent, as confirmed by a low kappa coefficient 
(0.21−0.38) [17]. It seems that the method of 
formulating the questions in the questionnaires 
may have an impact on these differences. The 
questions in the ISAAC study turned out to be 
more efficient. They concentrated not on a previ-
ous diagnosis, but on the symptoms and events, 
such as, e.g. previous hospitalisation for asthma 
(in the Denmark study one of the questions was: 
“did a doctor diagnose the child with asthma at 
any time previously?”).
Our data coming from disease registries are 
also subject to errors mainly associated with 
inaccuracy of diagnoses: population diagnosed 
with asthma may involve not only asthma but 
also ACOS (Asthma/COPD Overlap symptom), 
COPD (Chronic Obturatory Pulmonary Disease) 
and some other disorders. Other problems include 
incompleteness of data or difficulty in establish-
ing the population exposed to risk.
Key role in the epidemiology of asthma was 
played by two study projects: International Study 
of Asthma and Allergies in Childhood (ISAAC) and 
European Community Respiratory Health Survey 
(ECRHS). The data obtained from them not only 
supplemented the knowledge on the causes of 
asthma and other allergic diseases, but became the 
initial point for further epidemiological studies 
thereof. The ISAAC study has established asthma 
incidence differences of up to 15 times between 
various centres.  The ECRHS study (concerning 
persons aged between 20 and 44 and conducted in 
48 centres from 22 countries) also demonstrated 
the existence of geographical differences in the 
frequency of occurrence of asthma. It was most 
rarely diagnosed in Greece and Estonia (2%), and 
most frequently in Great Britain (8.4%) [18].
The first epidemiological study of asthma in 
Poland involving rural areas was PMSEAD pub-
lished as early as in 2007 (22). The main advan-
tage of this study, as compared to those conducted 
according to the ISAAC or ECRHS protocols, is 
that it was based on a sample of population liv-
ing in different parts of the country. Particular 
emphasis was placed on proper diagnosis and 
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selection of a wide range of patients aged 3 to 80 
years from both urban and rural environment. It 
was the first epidemiological study confirming 
the existence of a strong relationship  between 
increased prevalence of asthma and living in 
areas with higher black smoke pollution. How-
ever  study cohort was relatively small due to the 
study design (19,000). In 2003 Samoliński’s team 
conducted the pilot studies in Poland which indi-
cated that the problem of allergic diseases applies 
to approximately 25% of Poles.
The same team of experts has implemented 
in the years 2006−2008 a cross-sectional epide-
miological study, ECAP (Epidemiology of Allergic 
Diseases in Poland). It’s results indicate that the 
symptoms of asthma are present in 19.3% of chil-
dren in the age of 6−7 years, in 10.2% children 
in the age of 13−14 years and in 12.4% of adults 
in the age of 20−44 years (average of 13.6%). 
At the same time a significant difference could 
be observed in the frequency of occurrence of 
asthma between urban centres (on average 14%) 
and rural areas (on average 9.1%). The declared 
asthma (based on a survey study) was diagnosed 
in 4.4% of children in the age of 6−7 years, 6.2% 
of children in the age of 13−14 years and in 4% 
of adults (on average 4.6%, that is 1.7 million per-
sons). Here also significant differences between 
urban areas (average 4.8%) and rural areas (av-
erage 2.9%). Similar conclusions were obtained 
by Kulus in his study, which estimates asthma 
to be twice more frequently present in Warsaw 
than in Polish villages (22% compared to 11.4%) 
[19]. Also Kuna, referring to the results of studies 
conducted by Kupryś-Lipińska et al. within the 
area of Łódzkie province indicated that asthma is 
present in 18.4 percent of urban children and 6 
percent of children living in rural areas. Similar 
proportions are present in the adult population: 
13.2% of asthmatics in urban areas and 4.2% in 
rural areas [20, 21]. 
In addition, in 2008 NFZ introduced  funding 
of benefits associated with the diagnosis of the 
disease. This introduction of Diagnosis-Related 
Group (DRG) system resulted in improving the 
quality of  data transmitted by hospitals. After 
the initial period of the increase in the number of 
reported  patients in a specific group of diagnoses 
reporting of data has been stabilizing. 
To summarise epidemiological observations 
it should be emphasised that there is a significant 
difference in asthma prevalence depending on 
the region: urban vs rural. The average indicator 
of prevalence per 10,000 inhabitants for urban 
areas in the years 2008−2012 amounted to 306.8 
patients, with a prevalence for rural areas at a le-
vel of 250.9 patients. This indicates that for the 
studied period the average ratio of urban areas/
rural areas prevalence indicators is 1.22. The hi-
ghest difference occurred in 2008 (urban/rural = 
1.31), reaching a stable value of 1.23 in the next 
years. Analysing the prevalence value divided by 
regions the highest prevalence for urban regions 
occurs in the Świętokrzyskie province (indicator 
= 395.47; Fig. 3), and this value is stable over the 
entire studied period. Only for 2012 a similarly 
high value is present in the Wielkopolskie pro-
vince (indicator = 398.33). In case of rural areas 
a high value of averaged value of the morbidity 
indicator is present in multiple provinces: Świę-
tokrzyskie (indicator = 301.4); Śląskie (indicator 
= 306.02); Małopolskie (indicator = 293.69); 
Wielkopolskie (indicator = 290.30). 
 Conclusions
The results of analysis conducted on data 
concerning the health services provided to asth-
ma patients overlap with the data from previous 
studies conducted in Poland and worldwide. 
Thus it seems that this data may be confirmed in 
the future for epidemiological studies of asthma.
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